J F Flaherty - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J F Flaherty

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Clinical Pharmacokinetics|January 1, 1997

Grepafloxacin pharmacokinetics in individuals with hepatic dysfunctionC Efthymiopoulos, S L Bramer, A Maroli, et al.

Clinical Pharmacology and Therapeutics|March 1, 1989

Pharmacokinetics of esmolol and ASL-8123 in renal failureJ F Flaherty, B Wong, G La Follette, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1988

Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimensJ F Flaherty, L C Rodondi, B J Guglielmo, et al.

Journal of Viral Hepatitis|September 24, 2016

No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatmentY Liu, A C Corsa, M Buti, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Clinical Pharmacokinetics|January 1, 1997

Grepafloxacin pharmacokinetics in individuals with hepatic dysfunctionC Efthymiopoulos, S L Bramer, A Maroli, et al.

Clinical Pharmacology and Therapeutics|March 1, 1989

Pharmacokinetics of esmolol and ASL-8123 in renal failureJ F Flaherty, B Wong, G La Follette, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1988

Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimensJ F Flaherty, L C Rodondi, B J Guglielmo, et al.

Journal of Viral Hepatitis|September 24, 2016

No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatmentY Liu, A C Corsa, M Buti, et al.

Pageof 3